ciprofibrate [orch, phsu]
Profile [lbpr]
Management [ocac]
Hyperlipidaemia [dsyn]
Dietary [food]
Lifestyle Therapy [hlca]
Proportion [qnco]
Patients [podg]
Drug Therapy [topp]
Currently [tmco]
Available [ftcn]
choices [inbe]
Statins [orch, phsu]
Value [qnco]
Raised [qnco]
Cholesterol [bacs, strd]
Low dose [qnco]
resins [bodm]
Place [spco]
treating [topp]
Moderate [qlco]
Hypercholesterolaemia [dsyn]
Role [socb]
Fibrates [orch, phsu]
MODIFY [ftcn]
State [geoa]
Low density lipoprotein [aapp, bacs, lipd]
Metabolism [orgf]
ciprofibrate [orch, phsu]
Compound [qlco]
newly [idcn]
introduce [ftcn]
United Kingdom [geoa]
Share [socb]
PHARMACOKINETIC [resa]
properties [qlco]
Fibrates [orch, phsu]
Time [tmco]
Maximum Concentration [qnco]
Serum [bdsu]
One [qnco]
Hour [tmco]
Long [qlco]
Elimination Half Life [qnco]
hours [tmco]
Permit [rnlw]
Once daily [tmco]
treatment [ftcn]
Type [qlco]
IL [geoa]
Patients [podg]
Low Density Lipoprotein Cholesterol [bacs, strd]
Reduced [qlco]
More [ftcn]
Recent [tmco]
Work [ocac]
Show [inpr]
Fall [fndg]
Type [qlco]
ILA [gngm]
Patients [podg]
Low Density Lipoprotein Cholesterol [bacs, strd]
Increase [ftcn]
Cholesterol, HDL [bacs, lipd]
ciprofibrate [orch, phsu]
GIVEN [cnce]
mg day [qnco]
Triglyceride [bacs, lipd]
reduction [npop]
Record [inpr]
Type [qlco]
Patients [podg]
Favorable [qlco]
effects [qlco]
Follow-up [fndg]
Patients [podg]
Type [qlco]
Type [qlco]
Type IV [clas]
Patterns [spco]
effects [qlco]
Clotting [ortf]
Parameters [fndg]
Favorable [qlco]
Long-Term Effect [phpr]
Biliary [ftcn]
Cholesterol [bacs, strd]
Saturation [phpr]
Addition [ftcn]
Structural [spco]
Change [ftcn]
Observed [ftcn]
Small [qnco]
biopsies [diap]
treated [topp]
Liver [bpoc]
side effects [ftcn]
contraindications [qlco]
Fibrates [orch, phsu]
ciprofibrate [orch, phsu]
To [qlco]
Addition [ftcn]
Drug Therapy [topp]
Management [ocac]
Variety [cnce]
Dyslipidaemia [dsyn]
